Antibody Discovery Platform
Using classic murine hybridoma technology, the mature and stable process supports flexible immunogen and purification choices and yields hybridoma cell lines that passage stably.
Classic murine hybridoma technology on a mature, stable route: immunogen and purification options are flexible, success rates are high, and the antibodies obtained are highly specific and pure.
The hybridoma line passages stably, keeping quality reliable and batches consistent — the right fit when the same antibody must be supplied for years, as with diagnostic raw materials and tool antibodies.
Mouse monoclonal and anti-idiotypic monoclonal services can both select this platform.
Enquire now →
Four stages. The platform is a screening route for mouse monoclonal and anti-idiotypic monoclonal services, starting once immunization is complete and the titre is met.
Immunized splenocytes are fused with myeloma cells to form hybridomas
Selective medium isolates successfully fused hybridomas
ELISA identifies positive wells, and repeated subcloning yields monoclonal lines
Stably passaging hybridoma lines are expanded and cryobanked
Classic murine hybridoma technology follows a mature, stable route with flexible immunogen and purification options, high success rates and antibodies of high specificity and purity. The hybridoma line passages stably, keeping quality reliable and batches consistent — the right fit when the same antibody must be supplied for years, as in diagnostics and tool antibodies.
Share the intended application and what you already have in hand. A scientist — not a sales rep — will scope feasibility, suggest the right route and send a quote, usually within one business day.
